News

Podcast

Evolution Inspires Anthrax Cure

Scientists borrowed tricks from evolution to develop the world's first treatment for late stage inhalation anthrax.

Research

Chemists Garner New Insights into Protein Linked to Alzheimer’s Disease

A mutation in a normal protein can create amyloid β, a key contributor to Alzheimer's disease, researchers have found.

Features

A Peek Into the Minds of Award-Winning Educators

The College of Natural Sciences is currently celebrating Discovery Education Week to promote and discuss science education throughout the college.

Accolades

Chemistry Educator Receives Dads’ Association Centennial Teaching Fellowship

The fellowship recognizes excellence and commitment in the teaching of undergraduates.

Research

Drug Engineered at UT Austin to Treat Anthrax Gains FDA Approval

The anthrax antitoxin obiltoxaximab received approval March 21 from the U.S. Food and Drug Administration (FDA).

Accolades

Chemistry Chair Receives Major Award from American Chemical Society

“For outstanding contributions to physical and biophysical chemistry, especially work on protein and RNA folding, protein aggregation, and effects of molecular crowding in cells.”

UT News

UT Austin Professors Named Fellows of the National Academy of Inventors

Jonathan Sessler of the Department of Chemistry and George Georgiou of the Department of Molecular Biosciences at The University of Texas at Austin have been named Fellows of the National Academy of Inventors (NAI).

Features

Visualizing Science 2015: Beautiful Images From College Research

As part of a continuing tradition, we invited faculty, staff and students in the College of Natural Sciences community to send us images this past spring that celebrated the magnificent beauty of science and the scientific process. Our goal was to find those moments where science and art become one and the same.

Podcast

Fun With Chemistry

Kate Biberdorf combines the energy of a kickboxer with a passion for chemistry and a love of sharing science with the public

Features

Company Founded by Cancer-Fighting Chemist Sold for $21 Billion

Jonathon Sessler's Pharmacyclics company aided in advancing molecules to target cancer and was recently bought by AbbVie.